Abstract:
The invention provides purified proteins, DNA sequences that code on expression therefore and recombinant DNA molecules, including hosts transformed therewith for transforming coffee plants to suppress the expression of enzymes necessary for ethylene synthesis. The DNA sequences and recombinant DNA molecules are characerized in that they code on expression for the enzymes ACC synthase or ACC oxidase that are elements of the pathway for ethylene biosynthesis in coffee plants. Coffee plants are transformed with vectors containing ACC synthase and/or with ACC oxidase DNA sequences that code on expression for the respective mRNA that is antisense to the mRNA for ACC synthase and/or ACC oxidase. The resulting antisense mRNA binds to the respective ACC synthase and/or ACC oxidase mRNA, thereby inactivating the mRNA encoding one or more enzymes in the pathway for ethylene synthesis. The described DNA sequences can also be used to block synthesis of ACC synthase or ACC oxidase using co-suppression. The result in either event is that the transformed plants are incapable of synthesizing ethylne, though other aspects of their metabolism is not affected.

Description:
This application is a continuation-in-part of Ser. No. 08/485,107 filed Jun. 7, 1995, now U.S. Pat. No. 5,767,376. 
    
    
     FIELD OF THE INVENTION 
     This application relates to purified proteins, recombinant DNA sequences, hosts transformed therewith and processes for controlling the ripening of coffee plants. More particularly, this application relates to purified proteins, and recombinant DNA sequences that can be used to suppress the expression of coffee fruit-specific 1-aminocyclopropane-1-carboxylic acid (ACC) synthase and ACC oxidase genes. This application further relates to coffee plants transformed with such sequences, thereby rendered incapable of synthesizing ethylene necessary for ripening. Application of exogenous ethylene to plants transformed in accordance with this invention makes it possible to synchronize and control fruit ripening in coffee plants. 
     BACKGROUND OF THE INVENTION 
     Coffee is prepared from the roasted beans of the plants of the genus Coffea, generally from the species C. arabica. Beans are the seeds of the coffee plant and are obtained by processing the fruit, most ideally mature fruit which commands the best price due to its superior quality. In the past, high quality &#34;gourmet&#34; coffee was hand picked. This is necessary because the fruits of a coffee tree do not ripen uniformly and thus there are both mature and immature fruit on the same tree. In the past, this was not a serious problem as most coffee is grown in areas of the world where labor is plentiful and not expensive. However, more recently lack of abundant and inexpensive labor has become a major contributor to decreased productivity in coffee production. To increase productivity some regions of the world, such as the largest coffee producing country, Brazil, have resorted to strip harvesting where workers rapidly remove all fruit from a branch whether ripe or unripe. This increases the speed of harvesting but decreases the yield of the highest quality beans as much of the fruit is immature (green). 
     Furthermore, the lack of uniform ripening has seriously limited the effectiveness of mechanical harvesting. The force required to remove mature fruit (cherry) from the tree is similar to the force required to remove green fruit. Thus, mechanical harvesters do not distinguish well between green and cherry and a large amount of immature fruit is harvested along with mature fruit. This greatly decreases the yield of mature fruit and limits productivity. If coffee fruit ripening could be controlled so that all fruit ripened at one time, both the strip method of hand harvesting and mechanical harvesting would be much more efficient and a higher percentage of the harvested fruit would be in the higher quality grades. This would increase profitability of coffee production. 
     As is the case with many other fruit  Yang and Hoffman, Ann. Rev. Plant Physiol. 35:155 (1984)!, plant-produced ethylene plays an important role in the final stages of fruit ripening in coffee. Once coffee fruit reach a certain stage of maturity they can be induced to ripen by the exogenous application of ethylene  Crisosto, C. H., P. C. Tausend, M. A. Nagao, L. H. Fuchigami and T. H. H. Chen, J. Haw. Pac. Agri. 3:13-17 (1991). This demonstrates the importance of ethylene for the final stages of fruit ripening in coffee. 
     Ethylene is synthesized in a two-step reaction from S-adenosylmethionine (SAM). The first step is the synthesis of 1-aminocyclopropane-1-carboxylic acid (ACC) from SAM by ACC synthase. In most plants this is the rate limiting step. The final step is the conversion of ACC to ethylene which is catalyzed by ACC oxidase (Yang and Hoffman, supra). Inhibition of ethylene biosynthesis by chemical (e.g., silver ions or carbon dioxide) or biotechnological means  Oeller et al., Science 254:437 (1991)! inhibits the final stages of ripening. This inhibition is reversible by the application of ethylene. 
     Accordingly, a strategy for controlling the ripening of coffee plants is to prevent synthesis of specific enzymes in the pathway for ethylene biosynthesis. In one embodiment this invention relates to genetic alteration of coffee plants to eliminate synthesis of ACC synthase; in another, ACC oxidase synthesis is suppressed. In the presently preferred embodiments, synthesis of one or both of these enzymes is suppressed by transforming coffee plants with a DNA sequence that codes on transcription for a messenger RNA (mRNA) that is antisense to the mRNA that codes on expression for the enzyme whose synthesis is to be suppressed. See Oeller et al., Science 254:437 (1991), who reported controlling ripening of tomatoes using a similar strategy. 
     Recombinant DNA technology has been used to isolate a number of ACC synthase and ACC oxidase genes. However, the genes for ACC synthase and ACC oxidase in coffee have not been identified or sequenced to date. 
     SUMMARY OF INVENTION 
     The invention provides purified proteins, DNA sequences that code on expression therefore and recombinant DNA molecules, including hosts transformed therewith, for transforming coffee plants to suppress the expression of enzymes necessary for ethylene synthesis. The DNA sequences and recombinant DNA molecules are characerized in that they code on expression for the enzymes ACC synthase or ACC oxidase that are elements of the pathway for ethylene biosynthesis in coffee plants. 
     Coffee plants are transformed with vectors containing ACC synthase and/or with ACC oxidase DNA sequences inserted so that the transforming sequences code on expression for the respective RNA that is antisense to the mRNA for ACC synthase and/or ACC oxidase. The resulting antisense RNA binds to mRNA(s), thereby inactivating the mRNA encoding one or more enzymes in the pathway for ethylene synthesis. The described DNA sequences can also be used to block synthesis of ACC synthase or ACC oxidase using co-suppression. The result in either event is that the transformed plants are incapable of synthesizing ethylene, though other aspects of their metabolism is not affected. 
     Ripening in the transformed plants can be regulated by exogenous ethylene. By application of ethylene to the entire plant, the entire plant will ripen at once, making mechanical harvesting of coffee more productive. 
    
    
     SUMMARY OF THE DRAWINGS 
     FIG. 1 is the complete sequence of the cDNA encoding coffee fruit expressed ACC synthase. 
     FIG. 2 is the amino acid sequence of the coffee fruit ACC synthase deduced from the cDNA sequence shown in FIG. 1. 
     FIG. 3 is the sequence of the cDNA encoding coffee fruit expressed ACC oxidase. 
     FIG. 4 is the amino acid sequence of the coffee fruit ACC oxidase deduced from the cDNA sequence shown in FIG. 3. 
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     In order that the invention herein described may be more fully understood, the following detailed description is set forth. In the description the following terms are employed: 
     Nucleotide--A monomeric unit of DNA or RNA consisting of a sugar moiety (pentose), a phosphate, and a nitrogenous heterocyclic base. The base is linked to the sugar moiety via the glycosidic carbon (1&#39; carbon of the pentose) and that combination of base and sugar is called a nucleoside. The base characterizes the nucleotide. The four DNA bases are adenine (&#34;A&#34;), guanine (&#34;G&#34;), cytosine (&#34;C&#34;), and thymine (&#34;T&#34;). The four RNA bases are A, G, C, and uracil (&#34;U&#34;). 
     DNA Sequence--A linear array of nucleotides connected one to the other by phosphodiester bonds between the 3&#39; and 5&#39; carbons of adjacent pentoses. 
     Codon--A DNA sequence of three nucleotides (a triplet) which encodes through mRNA an amino acid, a translation start signal or a translation termination signal. For example, the nucleotide triplets TTA, TTG, CTT, CTC, CTA and CTG encode for the amino acid leucine (&#34;Leu&#34;), TAG, TAA and TGA are translation stop signals and ATG is a translation start signal, which also encodes the amino acid methionine (&#34;MET&#34;). 
     Polypeptide--A linear array of amino acids connected one to the other by peptide bonds between the amino and carboxy groups of adjacent amino acids. 
     Genome--The entire DNA of a cell or a virus. It includes inter alia the structural gene coding for the polypeptides of the substance, as well as promoter, transcription and translation initiation and termination sites. 
     Gene--A DNA sequence which encodes through its template or messenger RNA (&#34;mRNA&#34;) a sequence of amino acids characteristic of a specific polypeptide. 
     Transcription--The process of producing mRNA from a gene or DNA sequence. 
     Translation--The process of producing a polypeptide from mRNA. 
     Expression--The process undergone by a gene or DNA sequence to produce a polypeptide. It is a combination of transcription and translation. 
     Plasmid--A nonchromosomal double-stranded DNA sequence comprising an intact &#34;replicon&#34; such that the plasmid is replicated in a host cell. When the plasmid is placed within a unicellular organism, the characteristics of that organism may be changed or transformed as a result of the DNA of the plasmid. For example, a plasmid carrying the gene for tetracycline resistance (TETR) transforms a cell previously sensitive to tetracycline into one which is resistant to it. A cell transformed by a plasmid is called a &#34;transformant.&#34; 
     Phage or Bacteriophage--Bacterial virus many of which consist of DNA sequences encapsidated in a protein envelope or coat (&#34;capsid&#34;). 
     Cloning Vehicle--A plasmid, phage DNA, cosmid or other DNA sequence which is able to replicate in a host cell, characterized by one or a small number of endonuclease recognition sites at which such DNA sequences may be cut in a determinable fashion without attendant loss of an essential biological function of the DNA, e.g., replication, production of coat proteins or loss of promoter or binding sites and which contain a marker suitable for use in the identification of transformed cells, e.g., tetracycline resistance or ampicillin resistance. A cloning vehicle is often called a vector. 
     Cloning--The process of obtaining a population of organisms or DNA sequences derived from one such organism or sequence by asexual reproduction. 
     Recombinant DNA Molecule or Hybrid DNA--A molecule consisting of segments of DNA from different genomes which have been joined end-to-end outside of living cells and able to be maintained in living cells. 
     cDNA--A DNA strand complementary to an mRNA that codes for a particular polypeptide. 
     The strategy for controlling ethylene biosynthesis in coffee plants according to the present invention relates in the first instance to determination of the genes that code on expression for two enzymes in the ethylene pathway: ACC synthase and ACC oxidase. Transformation of wild type coffee plants with constructs containing either or both genes in an orientation that is antisense to the normal genes is expected to block synthesis of the respective enzymes. Messenger RNA transcribed under direction from the transforming sequence will bind to mRMA transcribed under direction from the normal sequence, thereby inactivating the normal message and precluding enzyme synthesis. 
     To isolate the DNA sequences that code on expression for ACC synthase and ACC oxidase in coffee, we screened a cDNA library produced from coffee plant tissue with synthetic DNA probes containing nucleotide sequences expected to occur. These expected sequences were based on studies of nucleotide sequences that occur in genes that encode the respective enzymes, other climacteric plants and other plants. 
     In the present invention the cDNA corresponding to the gene encoding ACC synthase or ACC oxidase is used to transform embryonic coffee plants. The plasmid pBI-121 is used as a transforming vector. The sequences corresponding to DNA that codes on expression for ACC synthase or ACC oxidase is inserted into the plasmid in an inverted orientation adjacent to a cauliflower mosaic virus 35S promoter. RNA transcribed therefrom will be complementary to mRNA that encodes the amino acid sequence of the respective enzyme. Complete constructs are amplified in bacterial hosts. The hosts are disrupted and the amplified vector is attached to colloidal gold particles. The gold particles with adherent vectors are inserted into coffee plant tissue by propelling the particles at high speed at the cells as described in U.S. Pat. No. 5,107,065. Young plants successfully transformed are identified by antibiotic resistance. The transformed plants do not produce ACC synthase or ACC oxidase, depending on the gene used to transform the plants. Ripening of the transformed plants is initiated by application of exogenous ethylene. 
     EXAMPLE 1 
     Isolation of Coffee Fruit-Specific ACC Synthase cDNA 
     In order to isolate ACC synthase gene sequences involved in the ripening of coffee, a cDNA library was prepared from a mixture of coffee fruit pericarp and mesocarp tissue at different stages of ripeness. This library was screened using a PCR product synthesized from first-strand cDNA made from the same mRNA used to construct the library and degenerate oligonucleotide primers corresponding to consensus sequences derived from ACC synthase genes from other organisms. This example principally involved the isolation of mRNA, the construction of a cDNA library, and the subsequent steps involved in cloning the appropriate cDNA. 
     a) Isolation of mRNA 
     Total RNA was isolated from 66 g of pericarp and mesocarp tissue from several different developmental stages of coffee fruit (C. arabica L. cv Guatemalan) using the method of Levi et. al.,  Hort Science 27(12):1316-1318 (1992)!. Frozen coffee fruit pericarp and mesocarp tissue was powdered by grinding for about 2 minutes in a domestic coffee mill (Salton Model GC-5; Salton Maxam Housewares Group, Mt. Prospect, Ill.) with a small piece of dry ice. The powdered fruit tissue was added to 200 mL of 200 mM tris hydroxymethyl!aminomethane hydrochloride (tris-HCl) (pH 8.5), 1.5% sodium dodecyl sulfate (SDS), 300 mM LiCl, 10 mM disodium ethylenediaminetetraacetic acid (Na 2  EDTA), 1.5% sodium deoxycholate (w:v), 1.5% Nonidet P-40 (Sigma Chemical Co.) (v:v), 0.5 mM thiourea, 1 mM aurintricarboxylic acid, 10 mM dithiothreitol (DTT), 75 mM β-mercaptoethanol, 2% polyvinylpyrrolidone (PVP) and 2% polyvinylpoly-pyrrolidone (PVPP) and homogenized using a Polytron tissue homogenizer (Tekmar, Cincinnati, Ohio). After 2 minutes of homogenization, 200 mL of chloroform was added and homogenization continued for a further 3 minutes. The homogenate was transferred to 250 mL centrifuge bottles (Nalgene) and centrifuged for 15 minutes at 2,500×g. The upper aqueous phase was removed and mixed with 12 mL of 5M NaCl, equally divided into two centrifuge bottles, and 150 mL of ethanol was added to each bottle. The mixture was stored at -20° C. overnight. The RNA was collected by centrifugation at 4,000×g for 15 minutes at 4° C. The RNA was dissolved in 50 mL TE1 (50 mM tris-HCL  pH 8.0!, 10 mM Na 2  EDTA) and clarified by centrifugation at 12,000×g for 10 minutes at 4° C. The supernatant was transferred to a new centrifuge bottle and 3 mL of 5M NaCl and 30 mL of isopropanol were added. The contents were mixed and stored at -20° C. overnight. The RNA was collected by centrifugation at 14,000×g for 10 minutes. The RNA was washed with 20 mL of 70% ice-cold ethanol and collected by centrifugation as before. After drying under vacuum for 10 minutes, the RNA was resuspended in 50 mL of TE1 buffer and 10 mL of 12M LiCl was added. The solution was incubated at 4° C. for 48 hours and the RNA was collected by centrifugation at 14,000×g for 10 minutes and resuspended in 30 mL TE1 buffer. After the addition of 15 mL of 5M potassium acetate, the RNA was incubated overnight at 0° C., recovered by centrifugation at 14,000×g for 10 minutes and suspended in 50 mL TE1 buffer. Three mL of 5M NaCl and 110 mL of 95% ethanol were added and the RNA was incubated at -20° C. overnight. The RNA was recovered by centrifugation at 14,000×g for 10 minutes, washed with 20 mL of 70% ice-cold ethanol, recovered by centrifugation as above, dried under vacuum for 10 minutes and resuspended in 600 μL of TE1 buffer. The RNA was transferred into a microcentrifuge tube and centrifuged at 14,000 rpm for 30 minutes at 4° C. after which 300 μL was removed to each of two new microcentrifuge tubes. The original centrifuged tube was rinsed with an additional 300 μL of TE1 buffer. Eighteen μL of 5M NaCl and 636 μL of 100% ethanol were added to each of the three tubes. After mixing by inverting, the tubes were stored overnight at -20° C. The RNA was collected by centrifugation at 14,000 rpm for 30 minutes and washed with 1 mL of 70% ice-cold ethanol. After centrifugation and drying as above, the RNA was resuspended in 400 μL sterile H 2  O. A total of 1.04 mg total RNA was obtained. 
     Messenger RNA (polyA +   RNA) was isolated using the PolyATtract® mRNA Isolation System IV (Promega Corporation, Madison, Wis.). A total of two isolations were done as follows. For each isolation, 0.48 mg total RNA was dissolved in 800 μL of RNase-free water. After heating at 65° C. for 10 minutes, 3 μL of 50 pmole/mL biotinylated oligo(dT) and 20.7 μL of 20× SSC (1× SSC contains 150 mM NaCl and 15 mM sodium citrate) were added and the mixture was allowed to slowly cool to room temperature over a period of approximately 30 minutes. An aliquot of streptavidin paramagnetic particles (provided in the PolyATtrack® mRNA Isolation System IV) was washed 3 times in 0.5× SSC and resuspended in 0.1 mL of 0.5× SSC. The RNA solution containing the biotinylated oligo(dT) was added to the washed streptavidin paramagnetic particles. After a 10 minute incubation at room temperature, the paramagnetic particles containing the trapped mRNA were captured to the side of the tube using a magnet. 
     The supernatant was removed and the particles were washed four times with 0.3 mL of 0.1× SSC. The mRNA was removed from the biotinylated oligo(dT) particles by suspending in 200 μL RNase-free water. An additional elution was carried out by adding 150 μL of water sequentially to each of the two tubes. The elution fractions (550 μL) were pooled and centrifuged at 14,000 rpm in a microcentrifuge for 30 minutes at 4° C. The supernatant was divided into two microcentrifuge tubes and, after the addition of 1/10th volume of 3M NaCl and 600 μL of ethanol, the mRNA was recovered by incubating the tubes at -20° C. overnight, followed by centrifugation as above. The mRNA was washed once with 1 mL of ice-cold 70% ethanol, dried and resuspended in 20 μL sterile H 2  O. One μL was added to 1 mL of water and a spectrum was obtained from 230 nm through 330 nm in a Shimadzu UV 160U spectrophotometer. Approximately 6 μg of mRNA was recovered from 1.04 mg of total RNA. 
     b) Construction of a cDNA Library 
     First and second strand cDNA was synthesized using the ZAP-cDNA synthesis kit (Stratagene, La Jolla, Calif.). Six micrograms of mRNA in 20 μL of water were incubated at 65° C. for 5 minutes. Two microliters of 100 mM methyl mercury were added and incubation was continued at room temperature for 10 minutes. Four microliters of 700 mM β-mercaptoethanol were added and the incubation was continued for an additional 5 minutes. To the denatured mRNA, 5 μL of 10× first strand buffer (provided in the kit), 5 μL of 100 mM DTfT, 3 μL nucleotide mixture (10 mM each dATP, dGTP, dTTP and 5-methyl-dCTP), 2 μL of 1.4 μg/μL linker-primer: 
     5&#39;-GAGAGAGAGAGAGAGAGAGAACTAGTCTCGAGTTTTTTTTTTTTTTTTTT-3 (SEQ. ID NO. 1) 
     1 μL RNase block and 5 μL of water were added. The reaction was incubated at room temperature for 10 minutes to anneal the primer to the mRNA and then 3 μL of 20 U/μL M-MuLV reverse transcriptase were added. Five microliters of this reaction mixture were removed to a tube containing 0.5 μL (0.625 pmoles) of 800 Ci/mmole  α- 32  P!dATP. Both reactions were incubated at 37° C. for 1 hour. The radioactively labeled reaction was frozen at -20° C. for later gel analysis. To the 45 μL main reaction, 40 μL of second strand buffer, 15 μL of 100 mM DTT, 6 μL of nucleotide mixture (10 mM dATP, dGTP, dTTP and 26 mM dCTP), 268.3 μL water and 2 μL (2.5 pmoles) of 800 Ci/mmol  α- 32  P!dATP were added. After mixing, 4.5 μL of 1 U/μL RNase H and 19.2 μL of 5.2 U/μL E. coli DNA polymerase I were added and the reaction was incubated at 16° C. for 2.5 hours. The reaction was extracted with 400 μL of phenol:chloroform (1:1). The phases were separated by centrifugation in a microcentrifuge for 5 min and the aqueous phase removed and re-extracted with chloroform. The aqueous phase was recovered by centrifugation as before. 
     The double-stranded cDNA was precipitated by the addition of 33.3 μL of 3M sodium acetate (pH 5.2) and 867 μL of 100% ethanol and incubation overnight at -20° C. The cDNA was recovered by centrifugation at 14,000×g in a microcentrifuge at 4° C. for 60 minutes. The cDNA was washed with 1 mL of 80% ethanol, recovered by centrifugation at room temperature in a microcentrifuge at 14,000×g, dried under vacuum and dissolved in 45 μL of water. Three microliters of the resuspended double-stranded cDNA was removed and stored at -20° C. for later analysis by gel electrophoresis. 
     To the remaining 42 μL of the double-stranded cDNA, 5 μL of 10× Klenow buffer (buffer #3; supplied by Stratagene), 2.5 μL of 2.5 mM nucleotides (dCTP, dGTP, dATP and DTTP), and 0.5 μL of 5 U/μL E. coli DNA polymerase I Klenow fragment were added. After 30 minutes at 37° C., 50 μL of water were added and the reaction was extracted with an equal volume of phenol:chloroform (1:1) and then chloroform as described above. After the addition of 7 μL of 3M sodium acetate (pH 5.2) and 226 μL of 100% ethanol, the blunt-ended double-stranded cDNA was incubated on ice for 30 minutes and recovered by centrifuging at 14,000 rpm at 4° C. for 60 minutes in a microcentrifuge. The cDNA was washed with 300 μL of 70% ethanol, centrifuged and dried as before. Seven microliters of 0.4 μg/μL EcoRI linkers were added to the dried cDNA. The structure of the EcoRI linkers are: 
     5&#39;-AATTCGGCACGAG-3&#39; (SEQ. ID NO. 2) 
     3&#39;-GCCGTGCTC-5&#39; 
     After vortexing to resuspend the cDNA, 1 μL of 10× ligation buffer, 1 μL 10 mM ATP and 1 μL of 4 Weiss U/μL T4 DNA ligase were added and the reaction was incubated over night at 8° C. The ligase was inactivated by heating at 70° C. for 30 minutes. The 5&#39; ends of the EcoRI linkers, that are now attached to the cDNA, were phosphorylated using polynucleotide kinase. One microliter of 10× buffer #3 of the ZAP-cDNA synthesis kit (Stratagene, La Jolla, Calif.), 2 μL of 10 mM ATP, 6 μL of water and 1 μL of 10 U/μL T4 polynucleotide kinase were added to the ligation reaction. After 30 minutes at 37° C. the kinase reaction was stopped by heating the reaction at 70° C. for 30 minutes. XhoI &#34;sticky ends&#34; were generated at the end of the cDNA corresponding to the 3&#39; end of the mRNA by digestion of the XhoI site in the linker-primer. Twenty-eight μL of XhoI buffer and 3 μL of 40 U/μL XhoI were added to the cDNA and the reaction was incubated at 37° C. for 1.5 hours. 
     The cDNA, with EcoRI sticky ends at the 5&#39; end and XhoI sticky ends at the 3&#39; end (relative to the original mRNA), was size fractionated by passage through a Sephacryl S-400 spin column prepared as follows. Five μL of 10× STE  100 mM Tris (pH 7.0), 5 mM EDTA and 100 mM NaCl! were added to the cDNA and the cDNA was applied to the top of a 1 mL syringe containing Sephacryl S-400 (Pharmacia Biotech, Piscataway, N.J.). A 500 μL microcentrifuge tube was placed on the bottom of the syringe and the column was placed in a centrifuge tube and centrifuged at about 400×g for 2 minutes. Sixty μL of 1× STE were added to the top of the syringe, a new microcentrifuge tube was placed on the bottom of the column and the column was again centrifuged as before. This process was repeated until six fractions had been collected. About 10% of each fraction was electrophoresed on a 1% agarose gel to determine the size distribution of the cDNA in each fraction. The remainder of each fraction was extracted with an equal volume of phenol:chloroform and then chloroform as described above and precipitated by the addition of 2 volumes of 100% ethanol. After overnight incubation at -20° C. the cDNA was recovered by centrifugation in a microcentrifuge at 14,000 rpm for 60 minutes at 4° C. Each cDNA fraction was washed with 200 μL of 80% ethanol and dried as described above. cDNA fraction 1 was resuspended in 3 μL of sterile water, and cDNA fraction 2 was resuspended in 10.5 μL of sterile water. One-half μL of each of the two fractions was used to determine the quantity of DNA using the ethidium bromide plate detection method. Fractions 1 and 2, containing the largest cDNA molecules, were combined. The 12.5 mL combined fractions contained approximately 100 ng of cDNA. This fraction was reduced to 2.5 μL in a Speed-Vac and stored on ice. cDNA fraction 3 was resuspended in 10.5 μL of sterile water, and saved at -20° C. for later use. 
     One-hundred ng of cDNA from fraction 1 and 2 were ligated into 1 μg of Uni-ZAP™ (Stratagene, La Jolla, Calif.), a lambda ZAP vector that had been digested with EcoRI and XhoI. Fraction 1 and 2 cDNA (2.5/μL) were added to 0.5 μL of 10 X ligation buffer, 0.5 μL 10 mM ATP, 1 μL of 1 μg/μL Uni-Zap XR vector and 0.5 μL of 4 Weiss U/μL T4 DNA ligase. The reaction was incubated at 8° C. for about 44 hours. A 1 μL aliquot of the ligation reaction was added to one aliquot of the `Freeze-Thaw` extract from the Gigapack II Gold bacteriophage λ packaging kit (Stratagene, La Jolla, Calif.). Fifteen microliters of Sonic extract were added and the contents were gently mixed. The packaging was carried out at room temperature. After 2 hours, 500 μL of SM buffer and 20 μL of chloroform were added to each packaging reaction and the debris was removed by a short centrifugation in a microcentrifuge. The packaged phages were moved to a new microcentrifuge tube. Ten μL of chloroform were added and the packages phages were stored at 4° C. until used. A titer of this primary library indicated the presence of 0.7×10 6  recombinant plaques. 
     c) Amplification of primary library. 
     Six-hundred μL of E. coli XL1-Blue MRF&#39; (Stratagene, La Jolla, Calif.), grown to a density of 0.5 at O.D. 600 , and 32.5 μL of primary library stock were added to each of 16 tubes. After incubation at 37° C. for 15 min, 6.0 mL of 48° C. top agar (5 g/L NaCl, 2 g/L MgSO 4 . 7H 2  O, 5 g/L yeast extract, 10 g/L NZ amine  pH 7.5!, and 0.7% agarose) were added to each tube and the contents were plated on 150×15 mm NZY plates (5 g/L NaCl, 2 g/L MgSO 4 . 7H 2  O, 5 g/L yeast extract, 10 g/L NZ amine  pH 7.5!, and 15 g/L Difco agar). The plates were incubated overnight at 37° C. and then overlayed with 10 mL of SM buffer and incubated for a further 8 hours at 4° C. with gentle shaking. The SM buffer was collected with a sterile pipette and stored in a sterile 250 mL centrifuge bottle. Each plate was rinsed with an additional 10 mL of SM buffer which were collected and added to the previous SM buffer. Chloroform, to a final concentration of 5%, was added and the phage solution was incubated at room temperature for 15 minutes and then centrifuged at 2,000×g for 10 minutes to remove cell debris. The supernatant was recovered to a sterile polypropylene bottle and chloroform was added to a final concentration of 0.3%. The amplified library was stored at 4° C. 
     d) Plating of amplified library for screening for specific genes. 
     The amplified library was titered as described above. Approximately 50,000 recombinant plaques were added to 600 μL of E. coli XL1-Blue MRF&#39; that were grown as described above. After 15 min at 37° C., 6.5 mL of 48° C. top agar were added and the cells were plated on 150×15 mm NZY plates. Four plates containing a total of 200,000 recombinant plaques were prepared and incubated at 37° C. overnight. The plates were then chilled for 4 hours at 4° C., then used for preparing plaque lifts as described below. 
     e) Identification and Construction of Oligonucleotides Homologous to Coffee ACC Synthase Genes 
     In previous studies, described in United States patent application Ser. No. 08/485,107 the specification of which has been incorporated herein by reference, we identified base sequences common to ACC synthase occurring in a variety of plants, referred to herein as consensus sequences. Based on these studies, we developed a set of three (3) fully degenerate primers for PCR amplification of regions of coffee first strand cDNA corresponding to consensus sequences. The sequence of the primers used is: 
     ACS167: 5&#39;-GCCAAGCTTCCRTGRTARTCYTGRAA-3&#39; (SEQ. ID NO. 3) 
     ACS289: 5&#39;-TTYCARGAYTAYCAYGGHYT-3&#39; (SEQ. ID NO. 4) 
     ACS885: 5&#39;-CCHGGDARNCCYAWRTCTTT-3&#39; (SEQ. ID NO. 5) 
     f) Reverse Transcriptase reaction to obtain first-strand coffee cDNA. 
     The reverse transcriptase reaction to obtain first-strand cDNA was performed in a final volume of 20 μL using the GeneAmp RNA PCR Core Kit (Perkin Elmer, Foster City, Calif.). First, 0.9 μg of coffee fruit mRNA in 3 μL water was mixed with 1 μL of 50 μM random hexamer and 6 μL of sterile water in a microcentrifuge tube and incubated at 65° C. for 5 minutes. The mixture was left at room temperature for 2 minutes and the liquid was recovered to the bottom of the tube by a brief centrifugation. To this mixture 2 μL PCR buffer II (from the above mentioned kit), 4 μL 25 mM MgCl 2 , 2 μL 10 mM dNTP&#39;s, 1 μL RNAsin (20 u/μL), and 1 μL reverse transcriptase (50 u/μL) were added. The reaction was incubated at 42° C. for 1 hour after which the reverse transcriptase was heat inactivated in a 95° C. water bath for 5 minutes. 
     g) Polymerase chain reaction to amplify coffee ACC-synthase gene. 
     A polymerase chain reaction (PCR) (Saiki et al., 1988) was performed using the GeneAmp Kit described above in a 50 μL reaction containing 10 μL first-strand cDNA mix, 4 μL PCR buffer II, 1 μL 25 mM MgCl 2 , 2.5 μL of 20 μM ACS167 primer (SEQ. ID NO. 3), 2.5 μL 20 μM ACS885 primer (SEQ. ID. NO. 5), 29.5 μL sterile H 2  O, and 0.5 μL Taq DNA polymerase (5 u/μL). PCR conditions were 35 cycles of 94° C. for 1 minute, 44° C for 1 minute, and 72° C. for 2 minutes. The product of the PCR reaction was analyzed by agarose gel electrophoresis using 1.5% SeaPlaque agarose (FMC BioProducts, Rockland, Me.) and Hae III-digested φX174 DNA (Promega Corporation, Madison, Wis.) as size markers. A single PCR product of approximately 650 bp was obtained. 
     h) Amplification of PCR product with different primers. 
     The 650 bp fragment obtained above was excised from the gel and placed in a 1.5 mL microcentrifuge tube. After the addition of 200 μL of sterile water, the 650 bp fragment was heated to 90° C. for 5 minutes, cooled to room temperature and centrifuged at 14,000 rpm for 5 minutes in a microcentrifuge. The supernatant containing the amplified DNA was removed and placed in a new sterile 1.5 mL microcentrifuge tube. A 25 μL PCR reaction was carried out using 0.4 μL of the previously amplified DNA as template, 2.5 μL 10× PCR buffer (10 mM Tris-HCl pH 9.0, 0.1% triton X-100), 2 μL 25 mM MgCl 2 , 5 μL of 1 mM dNTPs, 1 μL of 20 μM ACS289 primer (SEQ. ID. NO. 4), 1 μL of 20 μM ACS885 primer (SEQ. ID. NO. 5), 12.8 μL H 2  O, and 0.3 μL Taq DNA polymerase (5 u/μL)(Promega Corporation, Madison, Wis.). The PCR was performed using 35 cycles of 94° C. for 1 minute, 45° C. for 1 minute, and 72° C. for 2 minutes Five μL of this reaction was electrophoresed in a 1.5% agarose gel as described above. A single product of approximately 603 bp was observed. Eighty μL of sterile water, 10 μL of 3M sodium acetate (pH 5.2), and 220 μL of 100% ethanol was added to the remainder of the reaction. After incubation at -20° C. overnight, the DNA was recovered by centrifugation at 4° C. for 30 minutes at 14,000 rpm. The DNA was washed with 400 μL of ice-cold 75% ethanol and resuspended in 25 μL of sterile water. The DNA concentration was determined to be 10 ng/μL using the ethidium bromide plate assay. 
     i) Labeling Coffee Fruit-Specific ACC Synthase DNA 
     A random primed probe was produced using the PCR-generated ACC synthase DNA and the Prime-a-Gene Kit (Promega Corporation, Madison, Wis.). Two and one-half μL of the DNA (25 ng) was added to 27.5 μL of sterile water and the DNA was denatured by boiling for 5 min. Ten μL of 5× labeling buffer, 2 μL of unlabeled dNTP&#39;s  20 μM each; dCTP, dGTP, dTTP!, 2 μL 1 mg/mL acetylated BSA, 1 μL 5u/μL E. coli DNA polymerase I Klenow fragment and 5 μL (50 μCi) of  α- 32  P!dATP (3,000 Ci/mmole) (Dupont-NEN) were added to give a final volume of 50 μL. After 1 hr at room temperature, the reaction was terminated by the addition of 2 μL of 0.5M Na 2  EDTA and boiling for 2 min. 
     j) Screening of amplified library with the ACC synthase-specific probe. 
     Plaque lifts of the four 150×15 mm NZY plates containing 50,000 recombinant clones each were prepared. Four 132 mm Magna nylon transfer membranes (Micron Separations, Incorporated, Westborough, Mass.) were wetted by placing them on chromatography paper saturated with 5× SSC buffer for approximately 10 sec. The membranes were placed on the plates containing the recombinant plaques for 5 min, removed and incubated, phage containing side up, for 2 min on chromatography paper saturated with 0.5M NaOH and 1.5M NaCl. The membranes were then neutralized by transferring onto chromatography paper saturated with 0.5 M tris-HCl (pH 8.0) and 1.5M NaCl, for 5 min. After a brief 20 sec treatment on chromatography sheets saturated with 2× SCC containing 0.2M Tris-HCl (pH 7.5), the filters were blotted dry. After 1 hour of air drying, DNA was cross-linked to the membranes by treatment with 12,000 μJoules of a 260 nm UV light in a UV Stratalinker 1800 (Stratagene, La Jolla, Calif.). 
     The four membranes were prehybridized at 65° C. for 2 hours in 100 mL 6× SSPE (52.2 g/L NaCl, 8.3 g/L NaH 2  PO 4 .H 2  O, 2.2 g/L Na 2  EDTA,  pH 7.4!), 5× Denhardt&#39;s solution (1 g/L Ficoll, 1 g/L polyvinylpyrrolidone, 1 g/L BSA  pentax fraction V!), 0.5% SDS and 100 μg/mL denatured herring sperm DNA in a Hybaid Mark II hybridization oven (National Labnet Company, Woodbridge, N.J.) using HB-OV-BL bottles. 
     Hybridization was carried out at 65° C. for 12 hours in 10 mL of 6× SSPE containing 0.5% SDS, 100 μg/mL denatured herring sperm DNA, and 52 μL of the random primed probe described above. At the end of the hybridization period the hybridization solution was removed and the membranes were briefly washed with 100 mL of 2× SSC containing 0.5% SDS at 65° C. They were then washed for an additional 30 min with the same amount of fresh buffer again at 65° C. The membranes were washed twice more for 30 min at 65° C. with 100 mL of 0.2× SSC containing 0.5% SDS, wrapped in a cellophane envelope and exposed to pre-flashed Fuji RX GCU  X-ray film at -70° C. for 24 hours. Ten positive clones were obtained. The region of the original plates corresponding to the identified plaques were removed and placed in 1 mL of SM buffer containing 20 μL chloroform. Of these ten, 5 were re-plated at lower densities and rescreened as above to obtain individual plaques. 
     k) Characterization of Coffee-Fruit ACC synthase cDNA clones. 
     The size of the putative coffee ACC synthase cDNA clones was determined by polymerase chain reaction using primers homologous to a portion of the T3 and T7 promoters present in the cloning vector and flanking the cDNA insertion site. The sequence of the primers are: 
     T3: 5&#39;-TAATACGACTCACTATAGGG-3&#39; (SEQ. ID NO. 6) 
     T7: 5&#39;-AATTAACCCTCACTAAAGGG-3&#39; (SEQ. ID NO. 7) 
     The conditions for PCR were as described above except that the temperature cycle was 95° C. for 1 min., 50° C. for 1 min. and 72° C. for 2 min. Analysis was by agarose gel electrophoresis as before. 
     The three largest clones were recovered as phagemids by in vivo excision. Two hundred μL of phage stock from a single plaque was mixed with 200 μL of E. coli XL1-Blue MRF&#39; grown to a density at O.D. 600  of 1.0. One μL of ExAssist (Stratagene, La Jolla, Calif.) helper phage (&gt;1×10 6  pfu/μL) was added and the tubes were incubated at 37° C. for 15 min. Three mL of sterile LB broth were added and they were incubated for 3 hours at 37° C. with shaking. After heating at 70° C. for 20 min and centrifugation at 1,000×g for 15 min, 1 mL of the supernatant, containing the excised pBluescript phagemid packaged as filamentous phage particles, was transferred to a sterile 1.5 mL microcentrifuge tube and stored at 4° C. Phagemids were recovered by adding 25 μL of the stock solution to 200 μL of E. coli Solar cells (Stratagene, La Jolla, Calif.) grown to a density of 1 when measured at O.D. 600 . After incubation at 37° C. for 15 min, 200 μL of the cell mixture was plated on 100×15 mm NZY agar plates containing 50 μg/mL ampicillin. The plates were incubated overnight at 37° C. Individual colonies were picked into 10 mL of LB broth containing 50 μg/mL ampicillin and grown overnight in a 37° C. shaking incubator. The cells were concentrated in a 1.5 mL sterile microcentrifuge tube by repeated centrifugation and the phagemid DNA was purified using the plasmid mini kit from QIAGEN. The bacterial pellets were washed with water and resuspended in 0.3 mL of buffer P1. Next, 0.3 mL of alkaline lysis buffer P2 was added, mixed gently, and incubated for less than 5 min at room temperature. Following the addition of 0.3 mL of chilled buffer P3 and mixing by inverting the tubes 6 times, the extracts were incubated on ice for 10 min and centrifuged at 14,000 rpm for 15 min in a microcentrifuge. The supernatants were removed and applied to QIAGEN-tip 20 columns that had been previously equilibrated with 1 mL of QDT buffer. The extracts were allowed to enter the resin of the columns by gravity flow. Once the flow had stopped, the columns were washed 4 times with 1 mL buffer QC. The DNAs were eluted by washing the QIAGEN-tip 20 columns with 0.8 mL buffer QF which was collected into 1.5 mL microcentrifuge tubes. The DNA was precipitated by the addition of 0.7 volumes (560 μL) of isopropanol. The tubes were immediately centrifuged at 14,000 rpm for 30 min and the supernatant carefully removed. The pellets, containing the DNA, were washed with 1 mL of ice-cold 70% ethanol, centrifuged as above, and air dried for 5 min. The DNA was resuspended in 50 μL sterile H 2  O. The concentration of DNA from one plasmid isolation was 0.1 μg/μL by fluormetric analysis. 
     Sequencing reactions were performed by mixing 8 μL of phagemid DNA (0.8 μg) with 4 μL of either T3 or T7 sequencing primers (0.8 pmol/μL). Automated DNA sequencing was carried out on these samples at the University of Hawaii Biotechnology Service Center. About 350 bp of sequence from both the 5&#39; and the 3&#39; end of the cDNA was obtained. New sequencing primers were synthesized based on sequences near the end of the previous sequences and used in the same manner to complete the sequence of both strands of the cDNA. The complete sequence of the coffee fruit-expressed ACC synthase cDNA is given in FIG. 1 and SEQ ID NO: 11. The deduced amino acid sequence of the coffee fruit-expressed ACC synthase is given in FIG. 2 and SEQ ID NO: 10. 
     The sequence of the coffee ACC synthase cDNA clone and deduced protein was compared with other ACC synthase genes present in GenBank. The cDNA isolated from coffee fruit shows from 68.3% to 58.1% identity to other ACC synthases present in GenBank. And, the protein sequence deduced from this cDNA shows from 67.9% to 50.5% identity to other ACC synthases. However, this cDNA is unique in that no other sequence greater than 1500 bp showed greater than 68.3% identity to it. 
     EXAMPLE 2 
     Isolation of Coffee Fruit-Specific ACC Oxidase 
     a) Synthesis of ACC Oxidase specific oligonucleotide primers. 
     The isolation of total RNA, mRNA, and the synthesis of coffee fruit-specific cDNA was as described above. 
     Twelve ACC oxidase sequences, obtained from GenBank, were aligned using the Pileup program of GCG (Genetics Computer Group, Madison, Wis.). A region approximately 1000 bp from the translation start codon was found to be conserved and a degenerate oligonucleotide primer 
     5&#39;-TCATIGCKKCRAKIGGTTC-3&#39; (SEQ. ID NO. 8) 
     corresponding to this region was synthesized. Inosine (I) was placed at positions showing no sequence conservation, since position could be any of A, T, G or C. Positions showing two-fold ambiguity were prepared with mixed residues (T/G or A/G). We also prepared a second primer homologous to a region of the papaya fruit-expressed ACC oxidase cDNA that had been previously cloned in our laboratory and situated approximately 372 bp from the translational start codon: 
     5&#39;-GACACTGTGGAGAGGCTGAC-3&#39; (SEQ. ID NO. 9) 
     The two primers were used in a PCR reaction to amplify a portion of the coffee fruit-expressed ACC oxidase cDNA. The PCR contained 0.2 μL (10 ng) cDNA fraction 3 (described in Example 1), 5 μL 10× PCR buffer, 3 μL 25 mM MgCl 2 , 1 μL of each of the four 10 mM dNTPs, 1 μL of a 20 μM solution of each primer, 0.3 μL Taq DNA polymerase (Promega Corporation, Madison, Wis.) and 38.5 μL water. PCR conditions were 35 cycles of 94° C. for 1 min, 50° C. for 1 min, and 72° C. for 1 min. A 5 min incubation at 72° C. was carried out after the last cycle. A 20 μL aliquot of the product was electrophoresed in a 1.5% agarose gel as described previously and revealed an approximately 800 bp product. The DNA was excised from the gel and mixed with 200 μL of sterile water in a 1.5 mL microcentrifuge tube. After boiling for 5 min, 2 μL was used as a template in a 50 μL PCR reaction as above using the same primers. Gel electrophoresis performed as described above using 20 μL of the PCR reaction indicated the presence of a single 800 bp product. To the remaining 30 μL of the PCR reaction 20 μL chloroform and 100 μL water was added. The contents were mixed and centrifuged for 2 minutes at 14,000 rpm in a microcentrifuge. The upper aqueous phase containing the DNA was removed to a clean microcentrifuge tube. A portion of this DNA was radioactively labeled by random primed synthesis as described above. 
     b) Screening of amplified library with random primed probe. 
     The amplified coffee-fruit cDNA described in Example 1 was used to prepare four 150×10 mm NZY plates as previously described. Prehybridization, hybridization and recovery of clones was as previously described except that the ACC oxidase sequence obtained by PCR was used as the probe. 
     c) Characterization of Coffee-Fruit ACC-oxidase cDNA clones. 
     The size of the coffee ACC-oxidase cDNA clones was determined by polymerase chain reaction using primers homologous to the T3 and T7 promoters as described in Example 1. 
     The sequence of the largest coffee ACC oxidase cDNA clone was obtained as described in Example 1 and compared with ACC oxidase genes present in GenBank. FIG. 3 and SEQ ID NO: 13 give the sequence of the coffee fruit-specific ACC oxidase. FIG. 4 and SEQ ID NO: 12 give the deduced amino acid sequence of this protein. The cDNA was determined to encode ACC oxidase because it is from 50.4% to 82.5% identical to other ACC synthases nucleic acid sequences present in GenBank. Also, the deduced protein sequence is from 32.5% to 86.5% identical to other ACC oxidases. 
     The foregoing examples are for illustrative purposes only, and should not be viewed as limiting the scope of applicants&#39; invention, which is set forth in the claims appended hereto. 
     
         __________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 13(2) INFORMATION FOR SEQ ID NO:1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 15 amino acid residues(B) TYPE: amino acid(C) STRANDEDNESS: Not Relevant(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(ix) FEATURE:(A) NAME/KEY: Fragment A(B) LOCATION: 17..1480(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:IleAsnTyrAlaSerGlyAlaSerGlyIleLeuAspGlnXaaGly151015(2) INFORMATION FOR SEQ ID NO:2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 14 amino acid residues(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:IleAsnTyrAlaSerGlyAlaSerGlyIleLeuAspGlnThr151014(2) INFORMATION FOR SEQ ID NO:3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: OTHER NUCLEIC ACID(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: Internal(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:ATNAAYTAYGCNAGYGGNGC20(2) INFORMATION FOR SEQ ID NO:4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: OTHER NUCLEAR ACID(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: INTERNAL(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:ATNAAYTAYGCNAGYGGNGC20(2) INFORMATION FOR SEQ ID NO:5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: OTHER NUCLEIC ACID(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: INTERNAL(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:CGNCCAGNCGNYTAYTTNAT20(2) INFORMATION FOR SEQ ID NO:6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: INTERNAL(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:CGNCCYCTYGCYTAYTTNAT20(2) INFORMATION FOR SEQ ID NO:7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 14 amino acid residues(B) TYPE: amino acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(v) FRAGMENT TYPE: INTERNAL(ix) FEATURE:(D) OTHER INFORMATION: Xaa is either Thr or Asp(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:GlnTyrValProCysTyrPheXaaPheIleAspAspGlnAsp151014(2) INFORMATION FOR SEQ ID NO:8:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: OTHER NUCLEIC ACID(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: Internal(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:CAWTATGTNCCNTGTTATTT20(2) INFORMATION FOR SEQ ID NO:9:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: OTHER NUCLEIC ACID(A) DESCRIPTION: PRIMER(v) FRAGMENT TYPE: Internal(ix) FEATURE:(A) OTHER INFORMATION: N IS INOSINE(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:AAWTAWCAHGGNACWTATTG20(2) INFORMATION FOR SEQ ID NO:10:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 488 amino acid residues(B) TYPE: amino acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(ix) FEATURE:(A) NAME/KEY:CDS(B) LOCATION:178..1653(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:MetGluPheSerLeuLysAsnGluGlnGlnGlnLeuLeuSerLys151015MetAlaThrAsnAspGlyHisGlyGluAsnSerProTyrPheAsp202530GlyTrpLysAlaTyrAspSerAspProTyrHisProThrArgAsn354045ProAsnGlyValIleGlnMetGlyLeuAlaGluAsnGlnLeuCys505560PheAspLeuIleGluGluTrpValLeuAsnAsnProGluAlaSer657075IleCysThrAlaGluGlyAlaAsnLysPheMetGluValAlaIle808590TyrGlnAspTyrHisGlyLeuProGluPheArgAsnAlaValAla95100105ArgPheMetGluLysValArgGlyAspArgValLysPheAspPro110115120AsnArgIleValMetSerGlyGlyAlaThrGlyAlaHisGluThr125130135LeuAlaPheCysLeuAlaAspProGluAspAlaPheLeuValPro140145150ThrProTyrTyrProGlyPheAspArgAspLeuArgTrpArgThr155160165GlyMetGlnLeuLeuProIleValCysArgSerSerAsnAspPhe170175180LysValThrLysGluSerMetGluAlaAlaTyrGlnLysAlaGln185190195GluAlaAsnIleArgValLysGlyPheLeuLeuAsnAsnProSer200205210AsnProLeuGlyThrValLeuAspArgGluThrLeuIleAspIle215220225ValThrPheIleAsnAspLysAsnIleHisLeuIleCysAspGlu230235240IleTyrSerAlaThrValPheSerGlnProGluPheIleSerIle245250255SerGluIleIleGluHisAspValGlnCysAsnArgAspLeuIle260265270HisLeuValTyrSerLeuSerLysAspLeuGlyPheProGlyPhe275280285ArgValGlyIleLeuTyrSerTyrAsnAspAlaValValSerCys290295300AlaArgLysMetSerSerPheGlyLeuValSerThrGlnThrGln305310315HisLeuIleAlaSerMetLeuSerAspGluAlaPheMetAspLys320325330IleIleSerThrSerSerGluArgLeuAlaAlaArgHisGlyLeu335340345PheThrArgGlyLeuAlaGlnValGlyIleGlyThrLeuLysSer350355360SerAlaGlyLeuTyrPheTrpMetAspLeuArgArgLeuLeuArg365370375GluSerThrPheGluAlaGluMetGluLeuTrpArgIleIleIle380385390HisGluValLysLeuAsnValSerProGlyLeuSerPheHisCys395400405SerGluProGlyTrpPheArgValCysPheAlaAsnMetAspAsp410415420GluSerValArgValAlaLeuArgArgIleHisLysPheValLeu425430435ValGlnGlyLysAlaThrGluProThrThrProLysSerArgCys440445450GlySerSerLysLeuGlnLeuSerLeuSerPheArgArgLeuAsp455460465GluArgValMetGlySerHisMetMetSerProHisSerProMet470475480AlaSerProLeuValArgAlaThr485(2) INFORMATION FOR SEQ ID NO:11:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 2040 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: cDNA to mRNA(ix) FEATURE:(A) NAME/KEY:CDS(B) LOCATION:178..1653(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:GTAATCTCTTCTAAAATCAACCATTCTCTTCATTCTTCACTTGACAAGGC50CACTGCATTCTTCATTCTTTCTTGATATATAGCCATTTTTTTCATTCTTT100CTTGATATATAGCCATTTTTTTCATTCTTTCTTCATTCATTGTCTGGAGA150AGTTGGTTGAGTTTTCTTGAAAATTCAAGCAAAACAATGGAGTTCAGT198MetGluPheSerTTGAAAAACGAACAACAACAACTCTTGTCGAAGATGGCAACC240LeuLysAsnGluGlnGlnGlnLeuLeuSerLysMetAlaThr51015AACGATGGACATGGCGAAAACTCGCCTTATTTTGATGGTTGG282AsnAspGlyHisGlyGluAsnSerProTyrPheAspGlyTrp202530AAGGCATATGATAGTGATCCTTACCATCCCACCAGAAATCCT324LysAlaTyrAspSerAspProTyrHisProThrArgAsnPro354045AATGGTGTTATACAGATGGGACTCGCAGAAAATCAGTTATGC366AsnGlyValIleGlnMetGlyLeuAlaGluAsnGlnLeuCys505560TTTGATTTGATCGAGGAATGGGTTCTGAACAATCCAGAGGCT408PheAspLeuIleGluGluTrpValLeuAsnAsnProGluAla6570TCCATTTGCACAGCAGAAGGAGCGAACAAATTCATGGAAGTT450SerIleCysThrAlaGluGlyAlaAsnLysPheMetGluVal758085GCTATCTATCAAGATTATCATGGCTTGCCAGAGTTCAGAAAT492AlaIleTyrGlnAspTyrHisGlyLeuProGluPheArgAsn9095100GCTGTAGCAAGGTTCATGGAGAAGGTGAGAGGTGACAGAGTC534AlaValAlaArgPheMetGluLysValArgGlyAspArgVal105110115AAGTTCGATCCCAACCGCATTGTGATGAGTGGTGGGGCAACC576LysPheAspProAsnArgIleValMetSerGlyGlyAlaThr120125130GGAGCTCATGAAACTCTGGCCTTCTGTTTAGCTGACCCTGAA618GlyAlaHisGluThrLeuAlaPheCysLeuAlaAspProGlu135140GATGCGTTTTTGGTACCCACACCATATTATCCAGGATTTGAT660AspAlaPheLeuValProThrProTyrTyrProGlyPheAsp145150155CGGGATTTGAGGTGGCGAACAGGGATGCAACTTCTTCCAATT702ArgAspLeuArgTrpArgThrGlyMetGlnLeuLeuProIle160165170GTTTGTCGCAGCTCCAATGATTTTAAGGTCACTAAAGAATCC744ValCysArgSerSerAsnAspPheLysValThrLysGluSer175180185ATGGAAGCTGCTTATCAGAAAGCTCAAGAAGCCAACATCAGA786MetGluAlaAlaTyrGlnLysAlaGlnGluAlaAsnIleArg190195200GTAAAGGGGTTCCTCTTAAATAATCCATCAAATCCATTGGGA828ValLysGlyPheLeuLeuAsnAsnProSerAsnProLeuGly205210ACTGTTCTTGACAGGGAAACTTTGATTGATATAGTCACATTC870ThrValLeuAspArgGluThrLeuIleAspIleValThrPhe215220225ATCAATGACAAAAATATCCACTTGATTTGTGATGAGATATAT912IleAsnAspLysAsnIleHisLeuIleCysAspGluIleTyr230235240TCTGCCACCGTCTTCAGCCAGCCCGAATTCATCAGCATCTCT954SerAlaThrValPheSerGlnProGluPheIleSerIleSer245250255GAAATAATTGAGCATGATGTTCAATGCAACCGTGATCTCATA996GluIleIleGluHisAspValGlnCysAsnArgAspLeuIle260265270CATCTTGTGTATAGCCTGTCCAAGGACTTGGGCTTCCCTGGA1038HisLeuValTyrSerLeuSerLysAspLeuGlyPheProGly275280TTCAGAGTTGGCATTTTGTATTCATATAATGACGCTGTTGTC1080PheArgValGlyIleLeuTyrSerTyrAsnAspAlaValVal285290295AGCTGTGCTAGAAAAATGTCGAGTTTCGGCCTTGTTTCAACA1122SerCysAlaArgLysMetSerSerPheGlyLeuValSerThr300305310CAAACTCAGCATCTGATTGCATCAATGTTATCGGACGAAGCA1164GlnThrGlnHisLeuIleAlaSerMetLeuSerAspGluAla315320325TTTATGGACAAAATCATTTCCACGAGCTCAGAGAGATTAGCT1206PheMetAspLysIleIleSerThrSerSerGluArgLeuAla330335340GCAAGGCATGGTCTTTTCACAAGAGGACTTGCTCAAGTAGGC1248AlaArgHisGlyLeuPheThrArgGlyLeuAlaGlnValGly345350ATTGGCACCTTAAAAAGCAGTGCGGGCCTTTATTTCTGGATG1290IleGlyThrLeuLysSerSerAlaGlyLeuTyrPheTrpMet355360365GACTTAAGGAGACTCCTCAGGGAGTCCACATTTGAGGCAGAA1332AspLeuArgArgLeuLeuArgGluSerThrPheGluAlaGlu370375380ATGGAACTTTGGAGGATCATAATACATGAAGTCAAGCTCAAT1374MetGluLeuTrpArgIleIleIleHisGluValLysLeuAsn385390395GTTTCACCAGGCTTATCTTTCCATTGCTCAGAACCAGGATGG1416ValSerProGlyLeuSerPheHisCysSerGluProGlyTrp400405410TTCAGAGTTTGCTTTGCCAACATGGACGACGAAAGTGTGAGA1458PheArgValCysPheAlaAsnMetAspAspGluSerValArg415420GTTGCTCTCAGAAGAATCCACAAATTTGTGCTTGTTCAGGGC1500ValAlaLeuArgArgIleHisLysPheValLeuValGlnGly425430435AAGGCAACAGAGCCAACAACTCCAAAGAGTCGCTGCGGAAGC1542LysAlaThrGluProThrThrProLysSerArgCysGlySer440445450AGCAAACTTCAACTCAGCTTATCTTTCCGCAGATTGGACGAA1584SerLysLeuGlnLeuSerLeuSerPheArgArgLeuAspGlu455460465AGGGTGATGGGATCGCATATGATGTCCCCTCACTCCCCGATG1626ArgValMetGlySerHisMetMetSerProHisSerProMet470475480GCTTCACCTTTGGTTCGGGCTACATAAATCATTTCTTGATCAGA1670AlaSerProLeuValArgAlaThr485TCATATAGCAAAGATTCCTGAGTAAATACTCGAAACCCTTTCTGGATAAC1720TGAAAAGAGAGTTGTTGATTCTTTGCTGTATCATACAAACACGTTACAGG1770CATTTTTTGGCCATCTGATGCGTGCAAATTGCATCAAATGCTTTTATTAT1820TGTCATATTCATTTGTGTACCTTGGTTTTCCTTGCCCTTCAGTCCTCCTT1870GTTTTTTGTTTCTTTGTTATTATTTTCTTCCAGTTGATCAGTTAAACGAA1920GGAAGCTCAATTGTTTCAAGCTATTAGTAACAGATCATTTTGTAATAGCA1970ATAGTTTCAGGATTCTGAAATGAAAGTTTATCATTTTTCCATCATTTTAA2020AAAAAAAAAAAAAAAAAAAA2040(2) INFORMATION FOR SEQ ID NO:12:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 318 amino acid residues(B) TYPE: amino acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(ix) FEATURE:(A) NAME/KEY:CDS(B) LOCATION:46..1003(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:MetAlaThrPheProLeuIleAspMetGluLysLeuAspGlyGlu151015GluArgAlaAlaThrMetGlyValIleLysAspAlaCysGluSer202530TrpGlyPhePheGluValLeuAsnHisGlyIleSerAsnGluLeu354045MetAspThrValGluArgLeuThrLysGluHisTyrLysLysCys505560MetGluLeuLysPheLysGluMetValGluSerLysGluLeuGlu657075AlaValGlnThrGluIleAsnAspLeuAspTrpGluSerThrPhe808590PheLeuArgHisLeuProValSerAsnIleSerGluValProAsp95100105LeuAspAspGluTyrArgLysValMetLysGluPheAlaLeuGln110115120LeuGluLysLeuAlaGluLeuLeuLeuAspLeuLeuCysGluAsn125130135LeuGlyLeuGluLysGlyTyrLeuLysLysAlaPheTyrGlyThr140145150LysGlyProThrPheGlyThrLysValSerAsnTyrProProCys155160165ProArgProGluLeuIleLysGlyLeuArgAlaHisThrAspAla170175180GlyGlyIleIleLeuLeuPheGlnAspAspLysValSerGlyLeu185190195GlnLeuLeuLysAspGlyGluTrpValAspValProProMetArg200205210HisSerIleValIleAsnIleGlyAspGlnLeuGluValIleThr215220225AsnGlyLysTyrLysSerValMetHisArgValIleAlaGlnPro230235240AspGlyAsnArgMetSerLeuAlaSerPheTyrAsnProGlySer245250255AspAlaValIleTyrProAlaProAlaLeuValGluLysGluAla260265270GluAspLysGlnIleTyrProLysPheValPheGluAspTyrMet275280285LysLeuTyrAlaGlyLeuLysPheGlnAlaLysGluProArgPhe290295300GluAlaMetLysAlaValGluSerThrValAsnLeuGlyProIle305310315AlaThrVal318(2) INFORMATION FOR SEQ ID NO:13:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 1320 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: cDNA to mRNA(ix) FEATURE:(A) NAME/KEY:CDS(B) LOCATION:46..1003(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:TGTAAACGAAGCATAAGCACAAGCAAACACAAACTAGAAAGAGAGATG48Met1GCTACATTCCCCCTAATCGACATGGAGAAGCTTGACGGTGAA90AlaThrPheProLeuIleAspMetGluLysLeuAspGlyGlu51015GAGAGGGCTGCCACTATGGGAGTCATAAAAGATGCTTGTGAA132GluArgAlaAlaThrMetGlyValIleLysAspAlaCysGlu2025AGCTGGGGCTTCTTTGAGGTGTTGAATCATGGGATATCTAAT174SerTrpGlyPhePheGluValLeuAsnHisGlyIleSerAsn303540GAGCTCATGGACACAGTGGAGAGGCTAACAAAGGAGCATTAC216GluLeuMetAspThrValGluArgLeuThrLysGluHisTyr455055AAGAAATGTATGGAACTAAAGTTCAAGGAAATGGTGGAGAGC258LysLysCysMetGluLeuLysPheLysGluMetValGluSer606570AAGGAATTGGAAGCTGTTCAGACTGAGATCAATGATTTGGAC300LysGluLeuGluAlaValGlnThrGluIleAsnAspLeuAsp758085TGGGAAAGTACCTTCTTCTTGCGCCATCTTCCTGTTTCCAAC342TrpGluSerThrPhePheLeuArgHisLeuProValSerAsn9095ATCTCAGAAGTCCCTGATCTTGATGATGAATACAGAAAGGTT384IleSerGluValProAspLeuAspAspGluTyrArgLysVal100105110ATGAAGGAATTTGCGTTGCAACTTGAGAAACTAGCAGAGCTC426MetLysGluPheAlaLeuGlnLeuGluLysLeuAlaGluLeu115120125CTGTTGGACTTGCTATGCGAGAACCTTGGCCTAGAGAAAGGC468LeuLeuAspLeuLeuCysGluAsnLeuGlyLeuGluLysGly130135140TATCTGAAGAAAGCCTTCTATGGCACCAAAGGACCAACCTTT510TyrLeuLysLysAlaPheTyrGlyThrLysGlyProThrPhe145150155GGCACCAAAGTCAGCAATTACCCTCCATGCCCTCGTCCAGAA552GlyThrLysValSerAsnTyrProProCysProArgProGlu160165CTGATCAAGGGCCTCCGGGCACACACCGATGCCGGCGGCATC594LeuIleLysGlyLeuArgAlaHisThrAspAlaGlyGlyIle170175180ATCCTGCTGTTCCAGGATGACAAGGTCAGCGGTCTCCAGCTC636IleLeuLeuPheGlnAspAspLysValSerGlyLeuGlnLeu185190195CTCAAGGATGGTGAATGGGTGGATGTTCCGCCTATGCGCCAC678LeuLysAspGlyGluTrpValAspValProProMetArgHis200205210TCCATTGTAATCAACATCGGCGACCAACTTGAGGTAATCACA720SerIleValIleAsnIleGlyAspGlnLeuGluValIleThr215220225AATGGAAAATACAAGAGTGTGATGCACCGGGTGATAGCTCAA762AsnGlyLysTyrLysSerValMetHisArgValIleAlaGln230235CCAGATGGGAACAGAATGTCACTAGCATCATTCTACAATCCA804ProAspGlyAsnArgMetSerLeuAlaSerPheTyrAsnPro240245250GGAAGTGATGCAGTGATCTATCCAGCACCGGCATTGGTTGAG846GlySerAspAlaValIleTyrProAlaProAlaLeuValGlu255260265AAAGAGGCAGAGGACAAGCAGATATATCCCAAGTTTGTGTTC888LysGluAlaGluAspLysGlnIleTyrProLysPheValPhe270275280GAGGACTACATGAAGCTCTATGCTGGCCTTAAGTTCCAAGCT930GluAspTyrMetLysLeuTyrAlaGlyLeuLysPheGlnAla285290295AAAGAGCCCAGGTTTGAAGCCATGAAGGCCGTGGAAAGCACC972LysGluProArgPheGluAlaMetLysAlaValGluSerThr300305GTAAACTTGGGTCCAATCGCAACTGTTTGAGATAATACACGCTTTGA1019ValAsnLeuGlyProIleAlaThrVal310315TCTGCTGCTGTCTTATAATGCGCGTTTGCGTAATCATATCCTAGCATAGT1069ATATCTGAGATCTGAGTCTGTATTGTGGTGTGAGTTTGGTTTAGCCCCTT1119GTTAATGCTTGGATTGGACTAGTTAAATGTGGAGCTGGTTTGTTAGATAA1169GATAGTCTTGCCAGGATCTTTGAGTAAATATGATTCTGCGGAAGTCTGCG1219GTGAATGATAACGTGTAAAGCAATCCGAAAGTTACCTTTCTGGGGCTTTG1269TCATATGCAATGGAGAAGGAATCTTCCAAAAAAAAAAAAAAAAAAAAAAA1319A1320__________________________________________________________________________